Healthcare stocks looking cheaper, but fund managers flag need for technical expertise
Add BT as a preferred sourceClaudia Tan HS
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
THE Covid-19 pandemic has brought biotechnology and pharmaceutical stocks into focus, and many healthcare plays have outperformed broader market benchmarks.
Nevertheless, fund managers believe the valuations of the sector remain attractive - especially in light of a recent sell-off.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
20 photos that show how dramatically Singapore has changed in two decades
Singapore’s key exports up 15.3% in March from electronics surge, exceeding forecasts
